Clinical Trial Update: Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis [Phase 4]

View source ↗

Summary

This clinical trial update outlines a Phase 4 study evaluating mirikizumab for Crohn's disease and ulcerative colitis in adults over 60. The trial is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Mirikizumab (mirikizumab)

Snippet

Sponsor: Rubix LS | Conditions: Crohn Disease (CD), Crohns Disease | Phase 4 | Status: NOT_YET_RECRUITING